Biotech Firm Develops Broad-Spectrum Antiviral Pill
A California-based biotechnology company is developing a single pill designed to target multiple viruses simultaneously. Similar results were observed for hepatitis B and C. Researchers note the drug's potential to reduce viral load and improve patient outcomes. Independent researchers, including Peter White at the University of South Wales, have raised questions regarding the transition from laboratory findings to human application. Scientists are developing a single-pill antiviral treatment designed to combat multiple viral illnesses regardless of the specific virus. This technology is intended to provide protection before specific vaccines can be developed. Researchers suggest the mechanism could be transformative for pandemic preparedness. The development follows scientific research into the origins of Feline Infectious Peritonitis (FIP).
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“What if you could take a single pill that worked against the cold, the flu, COVID, norovirus, RSV, and hepatitis without needing to know which one you actually had?”
“this drug that they've developed, this California biotech company is called MDL001, so you know it's not really that advanced as yet”
“The researchers at Model Medicines had set themselves a very ambitious goal, find a single drug that could block a biologic choke point shared by multiple viruses.”
“machinery that many viruses use to copy their genetic material and ripple”
“the MDL001 inhibited influenza A and B, multiple coronaviruses, plus the common cold, RSV, which is particularly dangerous in infants and the elderly, norovirus”
“reduced viral load in the lungs and lessened the severity of illnesses. Similar results hepatitis B and C. So this is important for the body of evidence segment.”
“A short course of a single pill you take when a viral illness strikes regardless of which virus is responsible. In the context of pandemic preparedness, a broad spectrum antiviral...”
“We'd taken it as far as we could, and it was at a time when there was great interest in antiviral drugs, you know, with HIV and hepatitis.”
“against Ebola, but anyway, when we tested all these compounds we found”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade